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Unstructured summary  
Developmental programming of non-communicable diseases is now an established 
paradigm. With respect to hypertension and chronic kidney disease, adverse events 
experienced in utero can affect development of the fetal kidney and reduce final nephron 
number. Low birth weight and prematurity are the most consistent clinical surrogates for 
a low nephron number, and are associated with increased risk of hypertension, proteinuria 
and kidney disease in later life. Rapid weight gain in childhood or adolescence further 
compounds these risks. Low birth weight, prematurity and rapid childhood weight gain 
should   alert   clinicians   to   an   individual’s   life-long risk of hypertension and kidney 
disease, prompting education to minimize additional risk factors and ensuring follow-up. 
Birth weight and prematurity are significantly impacted by maternal nutrition and health 
during pregnancy. Optimization of maternal health and early childhood nutrition could 
therefore attenuate this programming cycle and reduce the global burden of hypertension 
and kidney disease in the future.  
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Key messages:  
 Low birth weight and prematurity are significant risk factors for hypertension, 
proteinuria and chronic kidney disease in later life 
 Low birth weight and prematurity occur in 15% and 9.6% of live births 
respectively world  wide,  suggesting  a  high  proportion  of  the  world’s  children  are  
at risk of hypertension and kidney disease 
 Low birth weight and prematurity are associated with a congenital reduction in 
nephron number 
 Low nephron numbers are associated with higher blood pressures and greater 
susceptibility to kidney disease 
 High birth weight, especially as a result of exposure to maternal diabetes in utero, 
is associated with increased risk of proteinuria and kidney disease in later life 
 The risk of low birth weight and prematurity is impacted by maternal nutrition 
and health before and during  pregnancy,  as  well  as  the  mother’s  own  birth  weight,  
demonstrating the intergenerational effects of programming 
 Upward crossing of weight or body mass index centiles in childhood or 
adolescence, is associated with increased risk of high blood pressure, progression 
of renal disease, type 2 diabetes, obesity and cardiovascular disease in later life. 
These effects can be independent of birth weight 
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Hypertension is now the leading risk factor for global disease burden, and is a major 
cause and consequence of chronic kidney disease (CKD)1. Global deaths from kidney 
disease have risen by 83% since 19902. Recognition of the burden of CKD, its’   risk  
factors, and implementation of prevention strategies are therefore key to saving many 
lives. Increasingly, fetal and early childhood development are being recognized as 
important contributors to the development of non-communicable diseases (NCDs)3, 4. The 
Developmental Origins of Health and Disease concept is based on the epidemiologic 
observation of a graded risk for hypertension, type 2 diabetes, cardiovascular and CKD 
across the range of fetal and early childhood development3, 4. Acknowledgement of this 
paradigm is important because interventions to optimize fetal and child health as 
strategies to prevent adult NCDs have great potential economic, societal and individual 
benefit4. Many developing countries carry the dual burdens of under- and overnutrition 
contributing to the vicious cycles of poor maternal health, suboptimal fetal development 
and unhealthy childhood growth which all augment the risk of adult disease5, 6. In this 
manuscript we will describe how fetal and child health impact kidney development and 
risk of disease, focusing mainly on human studies, but utilizing animal data where 
necessary to provide more insight.  
 
IMPACT OF FETAL DEVELOPMENT ON KIDNEY FUNCTION AND 
OUTCOMES 
 
Twenty five years ago, Brenner and colleagues proposed that a congenital 
(developmentally programmed) reduction in nephron number may explain why some 
individuals are more susceptible to hypertension and renal injury than others7. A kidney 
with fewer nephrons was postulated to have a reduced filtration surface area, resulting in 
limitation of sodium excretion leading to higher blood pressures, as well as a reduced 
renal adaptive capacity in the setting of injury. This hypothesis suggested a plausible link 
between higher prevalences of hypertension and renal disease in populations with a 
higher incidence of low birth weight (LBW), where LBW was expected to be associated 
with lower nephron number (Figure 1)8. Consistent with this hypothesis, various animal 
models have confirmed the association of LBW with later-life hypertension, mediated, in 
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part, by a reduced nephron number acquired in utero (the pathophysiologic mechanisms 
impacting nephrogenesis are reviewed elsewhere)9. Similarly, in humans, LBW is a risk 
factor for hypertension and CKD as will be discussed below10. LBW is a marker of poor 
fetal growth. Risk factors for LBW vary in developed and developing countries, but the 
global incidence is 15%, suggesting that a large number of children born yearly are at risk 
of hypertension and kidney disease in later life (Figure 2)11. Given the complexity and far 
reaching impact of developmental programming, understanding the most proximal 
origins of hypertension and renal disease risk is crucial to developing public health 
strategies to reduce their global impact4.  
 
LBW is universally defined as a birth weight under 2.5 Kg, whereas high birth weight 
(HBW) is defined as above 4.0 or 4.5 Kg12. Other terms reflecting neonatal size include 
intrauterine growth restriction (IUGR), small for gestational age (SGA) and large for 
gestational age (LGA). For simplicity, we will use LBW to include all those with a birth 
weight under 2.5 Kg, including those that are SGA, and HBW to include those with birth 
weights above 4.0 – 4.5 Kg and LGA.  A premature infant, i.e. born before 37 weeks of 
gestation, is generally LBW, which may be an appropriate weight for gestational age 
(AGA) if growth occurred normally until birth, or SGA if growth was restricted12.  
 
Nephron number in humans 
It is now well established that the total number of nephrons in the normal adult human 
kidney varies widely13. While the average number of nephrons per kidney was assumed 
to be between 900,000 and 1 million, the observed range is over 10-fold13.  In the largest 
study to date (Monash series), total nephron number among 176 African Americans 
ranged from 210,332 to 2,702,079 and among 132 white Americans, ranged from 
227,327 to 1,660,23214. 
 
Birth weight correlates linearly with nephron number in humans, and nephron number 
was found to increase by 257,426 per kilogram increase in birth weight, suggesting by 
extrapolation that nephron numbers would be lower in people of LBW15. Although 
nephron numbers have rarely been measured in adults of known LBW, nephron numbers 
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were significantly reduced in LBW infants16, 17. It is important to appreciate that the total 
number of nephrons in an adult human kidney reflects the number of nephrons formed 
during development (nephron endowment) minus the number of nephrons subsequently 
lost,   therefore   cumulative   injury   over   time   may   contribute   to   a   kidney’s   reaching   a  
critically low nephron number, leading to disease13. Nephrogenesis in humans ends at 
around 36 weeks of gestation, after which no new nephrons can form16. In the Monash 
series, nephron number in 15 infants who died before the age of 3 months ranged 4.5-
fold, from 246,181 to 1,106,062, suggesting that much of the variation in adult human 
nephron number is determined before birth18. 
 
 
Developmental determinants of low nephron number  
The most robust clinical surrogates for low nephron number are LBW and prematurity. 
Not all factors impacting nephron number result in LBW, however, therefore awareness 
of risk factors for low nephron number per se is also important (Table 1).  The most 
important risk factors, some of which may be modifiable with public health interventions, 
include maternal health and nutrition, pre- and post-natal environments, prematurity and 
genetic predisposition19. 
 
Maternal factors impacting risk of LBW and prematurity should be considered risk 
factors for low nephron number in the offspring (Figure 1)20. Mothers who had 
themselves been of LBW, compared to non-LBW, had a higher odds of having LBW 
babies (OR 1.8, 95% CI 1.3-2.5) independent of socioeconomic conditions, suggesting a 
genetic or epigenetic intergenerational effect21. Hypertensive disorders of pregnancy 
occurred in 8.4 million women worldwide in 2004, and are major risk factors for LBW22. 
As outlined elsewhere in this series, risk of preeclampsia in a mother is increased by her 
being of LBW (OR 1.69, 95% CI 1.4 – 2.02), premature (OR 1.95, 95% CI 1.54-2.47), or 
by her parents being born in pre-eclamptic pregnancies (OR 2.2, 95% CI 2.0 - 2.4) 
demonstrating the complexity of intergenerational programming23-25. Pre-pregnancy 
maternal CKD and hypertension are also significant risk factors for preeclampsia, LBW 
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and preterm delivery26. In a Cuban cohort, maternal hypertension was associated with 
LBW, which in turn was associated with low nephron number17.  
 
The world-wide prevalence of gestational diabetes is poorly documented, but reportedly 
varies from 0.1 – 25.3%27. Maternal obesity, now occurring in 15 - 20% of pregnancies, 
is a strong risk factor for gestational diabetes, as is maternal prematurity25, 28. In 
experimental animals, maternal hyperglycemia is associated with reduced nephron 
number, higher blood pressures, microalbuminuria and reduced GFRs in offspring29. In 
humans, renal functional reserve was found to be reduced in adult children of diabetic 
mothers compared to diabetic fathers, suggesting a reduction in nephron number acquired 
during gestational diabetes exposure30. Maternal diabetes is also associated with a 3 fold 
increased risk of renal agenesis and dysgenesis, therefore hyperglycemia strongly impacts 
fetal renal development31. Furthermore, gestational diabetes is often associated with 
infant HBW, a known risk factor for subsequent hypertension, type 2 diabetes, renal and 
cardiovascular disease, although the impact on nephron number is unknown32.  
 
Maternal behaviors during pregnancy may impact fetal nephrogenesis. Maternal smoking 
has been associated with LBW and low nephron number in humans17. Alcohol 
consumption is associated with dose-dependent increased risk of prematurity and fetal 
growth restriction33. In animals, gestational alcohol exposure impairs embryonic ureteric 
bud branching, resulting in low nephron number, and may therefore be a risk in 
humans34. 
 
Prenatal factors: Maternal diets deficient in protein, total calories or iron have all been 
shown to reduce nephron numbers in experimental animals, most often associated with 
LBW9. In humans, maternal protein and micronutrient deficiencies are common in 
developing countries, and maternal malnutrition, underweight, iron deficiency and 
anemia are all recognized risk factors for LBW35. Vitamin A deficiency is also highly 
prevalent among pregnant women world-wide (Figure 2)36. In animals, maternal diets 
deficient in vitamin A, resulting in levels similar to those seen in deficient humans, 
induce a dose-dependent reduction in nephron number, whereas vitamin A 
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supplementation augments nephron number37. Importantly vitamin A deficiency alone 
does not cause LBW, suggesting the impact may be overlooked if a normal birth weight 
(NBW) is presumed to exclude an adverse developmental environment. The active 
metabolite of Vitamin A, Retinoic acid, regulates transcription of Ret, a tyrosine kinase 
receptor critical for kidney development. It is therefore plausible that vitamin A intake 
may be an important determinant of nephron number in humans. Indeed, maternal 
vitamin A deficiency was associated with significantly smaller newborn adjusted renal 
volume in Indian compared to Canadian infants, likely reflecting lower nephron numbers 
(Table 1)38.  
 
Prematurity occurs in 9.6% of live births (Figure 2) and is associated with higher blood 
pressures, renal and cardiovascular disease in later life12, 39. Nephron number correlates 
with gestational age in premature infants in whom nephrogenesis may continue for a 
period after birth, although glomeruli are large and abnormal and renal maturation 
appears accelerated16, 40. Consistent with these morphologic abnormalities, prematurity is 
a risk factor for acute kidney injury (AKI), which is an independent predictor of mortality 
and subsequent CKD in very low birth weight (VLBW) infants12.  
 
Post-natal factors: Nephrogenesis in humans is complete at term, however ongoing 
nephrogenesis has been observed up to 40 days after birth in infants born before 30 
weeks of gestation40. A window of vulnerability therefore exists in preterm infants in 
which kidney development can be impacted (Table 1). Indeed, extrauterine growth 
restriction was associated with significantly lower GFRs in VLBW children at a mean of 
7.6 years of age, and conversely the odds of renal impairment was 33% lower at 6.4 years 
among VLBW children who had gained more weight in neonatal intensive care, 
demonstrating the importance of early nutrition on kidney development41, 42. Nephron 
number was found to be lower in premature infants who developed renal failure before 
death, although whether this was a cause or consequence of low nephron number is 
unknown40.  
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Many premature infants receive perinatal medications such as non-steroidal anti-
inflammatory drugs, glucocorticoids and aminoglycosides. Extrapolating from animal 
models, these and other medications may impact nephron number as well as increase the 
risk of AKI in infants43. Interestingly, however, follow up of individuals exposed to 
betamethasone for 48 hours prior to birth did not reveal any increase in blood pressure at 
age 30 years compared to controls44. Short-term steroids may therefore not impact kidney 
development, but the effects of such common medications on human nephrogenesis 
requires further study. 
 
Genetics: Rare genetic and congenital abnormalities resulting in renal hypoplasia 
contribute to about half of all childhood end-stage renal disease (ESRD)45. Search for 
common polymorphisms in several genes known to participate in kidney development 
have shown correlations between altered gene transcription and newborn kidney size, 
which is proportional to nephron number(Table 1)18. These studies have been conducted 
in primarily Caucasian populations, therefore implications in other populations need to be 
investigated18, 46, 47. The molecular mechanisms regulating nephrogenesis are expertly 
reviewed elsewhere48. Individual permutations of these genetic variants may explain the 
wide variability seen in human nephron numbers, as some reduce and some augment 
kidney volume. Interaction between genetic polymorphisms and environmental 
circumstances during kidney development has not been studied. Gene microarray 
analysis of neonatal kidneys revealed global downregulation of gene expression in animal 
models of maternal low protein diet or placental insufficiency49. It is therefore 
conceivable that altered levels of gene expression resulting from a polymorphism may 
become even more amplified under conditions of superimposed maternal nutrient 
deficiency, further decreasing nephron number50. 
 
Clinical surrogates for nephron number  
At present, all reports of human nephron number have come from kidneys obtained at 
autopsy. Given the current reliance on autopsy specimens, surrogate markers for nephron 
number are important (Table 2). 
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Like total nephron number, mean glomerular volume was found to vary up to 10-fold in 
the Monash Series of 420 kidneys of subjects from five ethnic groups51.  Total nephron 
number consistently varies inversely with mean glomerular volume13. This increase in 
glomerular volume likely reflects compensatory hypertrophy and hyperfiltration in 
individual nephrons. Indeed, total filtration surface area is relatively preserved in kidneys 
with low nephron number, possibly at the expense of increased glomerular pressure, 
which can accelerate further nephron loss14. Consistent with this, increased glomerular 
size is a predictor of poorer renal outcomes among African Americans, Pima Indians and 
Aboriginal Australians, and in the absence of other causes, should be considered a 
surrogate for low nephron number9. Given the heterogeneity and hypertrophy occurring 
in glomeruli, kidney size has not been consistently found to correlate with nephron 
number in adults, but the relationship appears linear in infants under 3 months of age18, 52 
 
Clinical impact of nephron mass 
 
Birth weight, prematurity and blood pressure  
Studies among monozygotic twins, where the lighter twin was found to have higher 
subsequent blood pressures, suggest that environmental programming may be more 
crucial than genetic factors53. LBW and prematurity have consistently been associated 
with increased risk of higher blood pressure in later life (Table 3)54, 55. A recent meta-
analysis of 27 studies reported a 2.28 mmHg (95% CI, 1.24-3.33 mmHg) increase in 
systolic blood pressure in subjects who had a birth weight below compared to above 2.5 
Kg55. Unfortunately most studies to date have not distinguished between LBW as a result 
of growth restriction at any gestational age, or prematurity with AGA. The potential for 
unmeasured confounding or effect modification by gestational age and/or growth 
restriction, therefore, must be borne in mind 12. 
 
A systematic review of 10 studies including preterm subjects born at a mean gestational 
age of 30.2 weeks, with a mean birth weight of 1280 g, showed that blood pressures in 
later life were 2.5 mmHg higher (95% CI, 1.7 – 3.3 mmHg) than in subjects born at 
term54. Prematurity has predominantly been associated with higher, but still normal, 
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blood pressures as cohorts studied are still relatively young. Overt hypertension has been 
documented in 2 studies of premature subjects, one of 2 years olds where the prevalence 
of hypertension (defined as a systolic or diastolic blood pressure > 95th percentile) was 
30% overall, and another of pregnant women aged 25 years, where chronic hypertension 
was present in 1.4% of those born preterm compared to 0.8% born at term (OR 1.7; 95% 
CI, 1.32-2.20)25, 56. Several studies have tried to dissect the relative roles of prematurity 
and growth restriction. Some authors suggest prematurity alone is the predominant risk 
factor, whereas others have found SGA to be more important in determining risk of 
higher blood pressure and kidney disease57. These differences likely reflect the complex 
interplay of intra- and extra-uterine events and timing of insults which vary considerably 
in premature infants12.  
 
Given that the odd ratios for risk of higher blood pressures were similar in the meta-
analysis of LBW and the systematic review of prematurity, and that not all LBW is due to 
prematurity, both LBW and prematurity must be considered important risk factors for 
high blood pressure. The association starts in early childhood and becomes augmented in 
adulthood, at which stage blood pressures often reach hypertensive ranges, suggesting 
compounding of the programming effects by growth, age and lifestyle.  
 
Nephron number and blood pressure  
In rodents nephrogenesis continues for up to 7-10 days after birth, providing a window, 
as in human premature infants, where post-natal events may impact nephron number. In 
rats, rescue of nephron number in LBW rats, by optimization of post-natal nutrition 
abrogated the development of subsequent hypertension, and conversely, undernutrition of 
normal birth weight (NBW) rat pups after birth led to lower nephron numbers and higher 
blood pressure58, 59. These data are consistent with a role of nephron number in 
hypertension. In humans, among a cohort of German adults who died in accidents, 
nephron numbers were significantly lower among those with hypertension compared to 
normotensive controls60. Low nephron numbers have also been associated with higher 
blood pressures among Australian aboriginals and US and Australian whites, although 
birth weights were unknown61. The relationship between nephron number and blood 
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pressure among subjects of African origin appears less clear, but glomerular volume is a 
significant independent predictor of higher blood pressures in this population61. 
Additional factors likely contribute to hypertension among those of African origin, but 
the impact of birth weight, or a contribution of nephron number to severity of 
hypertension, for example, cannot be excluded. 
 
The observations in humans of normalization of glomerular filtration surface area despite 
low nephron numbers would tend to argue against the initial hypothesis suggesting a pure 
limitation of sodium excretion in this setting. Interestingly, however, in both humans and 
experimental animals, LBW and low nephron number have been associated with a salt-
induced increase in blood pressure (Table 3)62, 63. This salt sensitivity in young adults and 
children correlated inversely with birth weight, independent of GFR, suggesting a 
primary defect in renal sodium handling64, 65.  
 
Evidence that normalization of nephron number in some experimental models does not 
eliminate subsequent hypertension, however, points to additional factors participating in 
developmental programming of hypertension66. Elegant experiments have shown 
alterations in renal tubule sodium transporter expression, as well as systemic changes in 
vascular function, neuroendocrine adaptations to stress, insulin sensitivity and 
sympathetic nervous system activity66. Nephron number, therefore, is not the sole 
programmed risk factor for hypertension, but it is likely to exacerbate any risk and 
contribute to kidney disease. 
 
Renal function, birth weight and nephron mass  
Glomerular filtration rate: In the absence of compensatory hyperfiltration, a kidney with 
a reduced nephron number should have a reduced GFR. Indeed, GFR extrapolated from 
Amikacin clearance on day 1 of life, preceding any compensatory adaptation, was 
significantly reduced in premature and LBW infants compared to term controls67. GFR 
measured by inulin clearance was significantly lower at age 7.6 years in children who had 
been premature and had severe growth restriction compared to non growth restricted 
controls41. In this study, the effects were similar in children who experienced growth 
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restriction prenatally or post-natally in intensive care, again demonstrating the 
importance of early nutrition. Meta-analysis of 8 studies reported an odds ratio of 1.79 
(95% CI, 1.31 – 2.45) for a reduced GFR with LBW10.  
 
Proteinuria: Microalbuminuria is one of the earliest signs of glomerular hyperfiltration 
and transition to macroalbuminuria is consistent with ongoing renal injury. Hoy et al., 
first reported an odds ratio of 2.8 (95% CI, 1.26 – 6.31) of macroalbuminuria among 
Aboriginal Australians who had been of LBW compared to NBW68. In this population, 
albuminuria was associated with a significant increase in cardiovascular and renal deaths, 
emphasising   its’   clinical   relevance69. Since then, many studies have confirmed this 
association, reflected in an odds ratio of 1.81 (95% CI, 1.19 – 2.77) for albuminuria with 
LBW reported in a meta analysis of 9 studies10. Among Pima Indians, however, the 
relationship is U-shaped, with increased risk of proteinuria with birth weights both below 
2.5 Kg or above 4.5 Kg32. This population has a high incidence gestational diabetes, 
exposure to which was the strongest predictor of proteinuria in the HBW subjects32.  
 
Chronic kidney disease and ESRD: Several early studies found increased progression of 
primary renal diseases among subjects who had been of LBW (reviewed in (Luyckx, 
2010 #1432)). Among subjects with diabetes, prevalence of nephropathy has been 
associated with LBW and HBW, as well as short stature32, 70. All of these observations 
suggest that abnormal fetal growth increases long-term renal disease risk (Table 3). 
Consistent with this, the odds ratio for CKD, including ESRD, associated with LBW, was 
1.73 (95% CI, 1.44 – 2.08) among 18 studies10. Population-based studies have reported a 
U-shaped relationship between birth weight and risk of CKD or ESRD, suggesting HBW 
is also important8, 71, 72. Interestingly, in some studies the programmed risk of CKD 
appears greater in males71. The differential impact of gender on renal programming is, 
however, quite variable and requires further study72, 73  
 
As with programming of blood pressure risk, nephron number is unlikely to be the sole 
factor contributing to renal disease risk, and a low nephron number is unlikely sufficient 
 15 
to cause renal disease in the absence of additional “hits”. Moreover, developmental 
programming of related conditions, e.g. type 2 diabetes, cardiovascular disease, insulin 
resistance and obesity, may further increase renal risk4, 12. Programming of these 
disorders may occur simultaneously in a developing fetus, depending on timing and 
nature of the insults. All infants subjected to adverse intrauterine conditions should 
therefore be considered at risk for all of these disorders.  
 
 
IMPACT OF CHILDHOOD WEIGHT GAIN ON RISK FACTORS FOR CHRONIC 
KIDNEY DISEASE AND KIDNEY FUNCTION   
 
As discussed above, especially in premature and LBW infants, post-natal malnutrition 
and clinical circumstances may impact nephrogenesis, childhood renal function and long-
term renal disease risk (Figure 1)12, 40, 42. In LBW rats, low nephron numbers were 
restored to normal, and the development of hypertension abrogated by provision of 
adequate post-natal nutrition58. When LBW rats were overfed post-natally, nephron 
numbers remained low, and they developed obesity, hypertension and renal injury with 
time74. In post-natally overfed NBW rats, despite a higher than normal nephron number, 
blood pressure, proteinuria and glomerulosclerosis were all increased in adulthood75. 
Taken together, these data suggest that normalization of post-natal nutrition may be 
beneficial, but overfeeding is likely deleterious. In humans, post-natal weight gain and 
nutrition have also been implicated in developmental programming of adult disease76.  
 
“Catch-up”  growth  in  children  who  had  been  of  LBW has long been advocated especially 
in developing countries, improving an  infant’s  resilience  against  infections  and  reducing  
the risk of undernutrition, stunting and cognitive impairment5. Increasingly, however, in 
many populations world-wide, accelerated weight gain or increase in BMI, even in 
children with NBW, has been consistently associated with increased risk of adult 
hypertension, type 2 diabetes, and cardiovascular disease76-78. This effect increases with 
increasing age of the child; upward crossing of weight or BMI centiles in mid-childhood 
or adolescence is associated with strong adverse effects on later risk, while upward 
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crossing in infancy (below the age of 1 year) has no or minimal effect on later blood 
pressure and may protect against diabetes78-80. Importantly, the gain in childhood BMI 
associated   with   increased   risk   of   adult   disease   is   not   always   ‘excessive’   in   terms   of  
absolute number. In many developing countries, children that experience rapid growth 
may still be small by international weight standards, but upwards crossing of BMI 
centiles appears the critical factor78-80. A single cross-sectional  measurement  of  a  child’s  
weight or BMI therefore may be misleading in such circumstances, emphasizing the need 
for growth tracking in early childhood. 
 
LBW children in an environment of adequate nutrient supply tend to experience rapid 
weight gain5. Among 22-year-old British subjects, systolic blood pressure was 1.3 mmHg 
(95% CI, 0.3 -2.3 mmHg) higher for every standard deviation decrease in birth weight, 
and increased by 1.6 mmHg (95% CI, 0.6 – 2.7 mmHg) for every standard deviation 
increase in childhood weight gain between 1 and 10 years81. Many other studies have 
confirmed an association of rapid childhood weight gain with higher blood pressures and 
increased arterial stiffness, often already evident in childhood79.  
 
Among 216,771 Scandinavian subjects, those with a birth weight of 2.5 Kg and a BMI of 
17.7 Kg/m2 (overweight) at age 7, had a 44% increased risk of cardiovascular disease in 
adulthood compared with those with a median birth weight of 3.4 Kg and a BMI of 15.3 
Kg/m277. The highest risk of higher blood pressures and cardiovascular disease therefore 
occurred in children with LBW who become heavy77.  Importantly, BMI was strongly 
positively associated with cardiovascular disease risk in this study, independent of birth 
weight, demonstrating the importance of childhood obesity itself as a risk factor for adult 
disease.  
 
Childhood overweight and obesity are increasing world wide (Figure 2)82. Risk factors 
include HBW, exposure to gestational diabetes and early post-natal weight gain among 
many others83. Such risk factors are also independently associated with altered 
nephrogenesis and increased risk of hypertension, type 2 diabetes and renal dysfunction 
(Figure 1). In addition, obesity per se is a risk factor for progression of renal disease, 
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therefore superimposition of the burden of obesity on a small kidney with fewer nephrons 
is likely to compound the risk and act   as   a   “second   hit”   accelerating   renal   disease 
progression84. How best to optimize post-natal growth and positively impact subsequent 
disease risk, especially in LBW infants is not yet clear. Avoidance of obesity appears a 
safe guiding principle. 
 
Early growth and kidney function 
The association of rapid childhood weight gain with the renal disease risk factors of 
higher blood pressures, diabetes and obesity is likely to compound any primary 
programmed renal risk. Indeed, in a retrospective analysis of 80 children with proteinuric 
kidney disease, renal disease progressed fastest among those who had been premature 
and became obese85. Glomerular size was increased in all obese children, whether 
premature or term, whereas kidney size remained smaller among all those who had been 
premature independent of obesity. Similarly, among VLBW infants who developed 
neonatal AKI, excessive weight gain was a predictor of poorer renal function at a mean 
age of 7.5 ± 4.6 years86. How infant weight gain impacts long-term renal function 
remains unknown.  
 
Several potential mechanisms have been suggested to explain the amplification of renal 
and cardiovascular risk by rapid weight gain following growth restriction. One possible 
link is the development of premature senescence87. Cellular senescence is a state of 
growth arrest induced by upregulation of the cell cycle inhibitors p53, p21 and p16INK4a88. 
Upregulation of these genes may be induced by progressive telomere shortening, which 
occurs with cell replication and is a robust marker of aging, and by reactive oxygen 
species induced by cellular stress88. Chronic cardiovascular and renal diseases are 
associated with increased expression of senescence markers89. In animals, LBW followed 
by rapid postnatal weight gain was associated with shorter telomeres and increased 
expression of senescence markers in kidneys, hearts and aortas, as well as premature 
death, all consistent with accelerated aging87, 90, 91. Interestingly, LBW was also 
associated with a higher renal and cardiovascular mortality in an Australian Aboriginal 
cohort, which may be consistent with these experimental findings92.  Premature 
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senescence in the kidney may result from ongoing hyperfiltration injury in kidneys with 
fewer nephrons, compounded by a rapid increase in body size. In humans, leukocyte 
telomere length was not different between LBW and NBW British newborns, but among 
5 year old children from Bangladesh, telomeres were significantly shorter in those who 
were of LBW93, 94. Senescence is linked to oxidative stress. In children born SGA 
compared to controls, markers of oxidative stress were higher in those who experienced 
catch-up growth95. The link between nephron numbers, catch-up growth, premature 
senescence and the development of hypertension and renal disease in humans therefore 
appears plausible, but has not yet been confirmed.  
 
Conclusion 
 
 The association between fetal and childhood development and increased risk of adult 
disease is now quite convincing3. LBW and prematurity are associated with higher blood 
pressures and decreased renal function manifesting in early childhood, which may 
progress to overt disease in adulthood. Nutrition is a cornerstone of this association. 
Maternal nutrition and health prior to and during pregnancy are crucial in determining 
fetal growth and development of a kidney with enough nephrons to maintain homeostasis 
in response to dietary and metabolic stresses, as well as sustain function in the face of 
superimposed nephron loss. Early postnatal nutrition, especially after premature birth is 
also crucial in determining renal development. Upward crossing of weight or BMI 
percentiles after the infant period further programmes risk of hypertension and renal 
disease. The intergenerational impact of developmental programming is illustrated by 
LBW increasing the risk of maternal preeclampsia, obesity and gestational diabetes, 
which all in turn further compound future risks in their offspring. The growing 
knowledge and understanding of the pathophysiology of developmental programming has 
identified populations that   are   “at   risk”,   and   thus   should   be   targets   for   screening   and  
interventions to interrupt this cycle. Identification of nutritional deficiencies within 
populations (e.g. vitamin A deficiency) should prompt public health interventions to 
correct these deficiencies well before pregnancy. Adequate antenatal care should identify 
women who develop preeclampsia and gestational diabetes, optimize their care during 
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pregnancy, but also lead to lifestyle education and life-long screening of these women for 
later disease. Currently a minority of women worldwide are screened for gestational 
diabetes27. With the rising prevalence of obesity, such screening should be more 
widespread. Similarly, it has been estimated that only 60% of all children are weighed at 
birth (www.childinfo.org), this number should increase. Several interventions to reduce 
maternal and childhood malnutrition, where prevalent, have been shown to be effective: 
supplementation of protein energy intake during pregnancy reduced risk of term LBW by 
32%; supplementation of multiple micronutrients in pregnancy reduced LBW by 16%; 
implementation of malaria prophylaxis reduced risk of LBW by 37%96. Vitamin A 
supplementation did not affect birth weight, but reduced neonatal mortality (RR 0.8, 95% 
CI 0.66-0.96), whereas the relative risk of preeclampsia was 0.45 (95% CI 0.31–0.65) 
with maternal calcium supplementation96, 97. Thus far no study has followed the offspring 
of such supplemented pregnancies to determine whether risk of adult disease has been 
altered, it would be logical to assume a positive impact. In later life, regular 
cardiovascular exercise was shown to abrogate the metabolic consequences of being 
small at birth among adult men98. Identification of at-risk pregnancies and offspring, both 
high and low birth weight, therefore should prompt maternal education to optimize 
childhood nutrition and activity to prevent obesity. Prematurity and LBW are among the 
top ten contributors to the global burden of disease, calculations which may not always 
have included the long term costs of programmed adult NCDs1, 22. Acknowledgement of 
the role of developmental programming in hypertension and renal disease risk, and 
implementation of locally adapted preemptive strategies in individual countries, should 
have significant long term benefits in terms of future health, productivity and cost savings 
world wide. 
 
 
Search strategy and selection criteria: Articles reviewed for this manuscript were 
identified  by  searching  the  PubMed  database,  using  the  search  terms  “nephron  number”,  
“nephron   endowment”,   “nephron   mass”,   “nephrogenesis”,   “birth   weight”, “low   birth  
weight”,   “high   birth   weight”, “prematurity”,   “preterm   birth”,   “developmental  
programming”,  “developmental  origins  of  adult  health  and  disease”,  “catch-up  growth”,  
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“growth  restriction”,  “SGA”,  “IUGR”,  with  other  key  words  including  “kidney”,  “kidney  
mass”,   “kidney   size”,   “kidney   volume”,   “diabetes”,   “gestational   diabetes”,  
“cardiovascular  disease”,  “obesity”,  “human”,  “hypertension”,  “hypertensive  disorders  in  
pregnancy”,   “preeclampsia”,   “vitamin   A   deficiency”,   “maternal   diet”,   “maternal  
nutrition”. In addition, a snowball strategy was employed utilizing bibliographies of 
existing manuscripts, textbooks and websites. Data, references and links were also 
identified by searching the WHO, UNICEF and Google Scholar websites using key 
words  “low  birth  weight”,  “preeclampsia”,  “gestational  diabetes”,  “maternal and newborn 
health”,  “nutrition”,  “childhood  obesity”. We largely included publications from the last 
5 years, but also included older references that have been seminal in the field. Some 
references were included with animal data when these were considered necessary to 
explain concepts strongly supporting the pathophysiology but not yet proven in humans. 
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Table 1: Developmental factors associated with nephron number, kidney size and 
function 
Timing Condition Effect on kidney 
Prenatal 
 
Maternal vitamin A deficiency Small infant kidney size 
Low birth weight Decreased nephron number 
Growth restriction Reduced GFR at 7.5 years 
Prematurity Decreased nephron number 
Reduced kidney size in growth 
restricted children 
Genetics 
RET(1476A) polymorphism       10% reduction newborn kidney volume 
PAX2 AAA haplotype 10% reduction newborn kidney volume 
Combined RET(1476A) polymorphism and 
PAX2 AAA haplotype 
23 % reduction newborn kidney 
volume 
I/D ACE polymorphism 8 % reduction newborn kidney volume 
BMPR1A rs7922846 polymorphism  13% reduction newborn kidney volume 
OSR1rs12329305(T) polymorphism 12% reduction newborn kidney 
volume 
Combined OSR1 and RET polymorphisms 22% reduction newborn kidney volume 
Combined OSR1 and PAX2 polymorphisms 27% reduction newborn kidney volume 
Postnatal Renal failure Decreased nephron number 
Growth restriction Reduced GFR at 7.5 years  
Increased odds of renal 
dysfunction at 6.4 years 
“Catch-up”  growth,  childhood  and  adolescent  
overweight/obesity 
Increased glomerular volume 
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Faster progression of renal disease 
Prenatal Genetics 
ALDH1A2rs7169289(G) polymorphism 
 
22% increase newborn kidney size 
Adapted with permission from 99. RET –tyrosine kinase receptor; PAX2- paired box gene 2; ACE – angiotensin converting enzyme; 
OSR – Odd-Skipped related; BMPR – bone morphogenic protein receptor; ALDH – aldehyde dehydrogenase. Individual references 
listed in appendix.
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Table 2: Clinical surrogates for nephron number 
 
Adapted with permission from 99. Individual references listed in appendix
Clinical surrogate Association with nephron number 
Low birth weight ↑  of  257  426  glomeruli  per  kidney,  per  Kg  increase  in  birth  
weight  
Prematurity ↓  glomerular  number,  proportional  to  gestational  age,  in  
premature compared to term infants 
Gender Nephron number 12% lower in females 
Age ↓  3676  glomeruli  per  kidney  per  year  of  age  >  18  years  
(nephron loss) 
Adult height ↑  28  000  glomeruli  per centimeter increase in height 
Kidney mass  ↑  23459  glomeruli  per  gram  of  kidney  tissue  (in  infants) 
Glomerular volume Inverse correlation between glomerular volume and nephron 
number 
Ethnicity ↓  in  Aboriginal  Australians  compared  to  US  white  and  black 
Possible correlates 
Gestational diabetes 
exposure 
↓  renal  functional  reserve  in  offspring  of  diabetic  mothers  vs.  
diabetic fathers 
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Table 3: Clinical associations with programming of kidney function 
Adapted with permission from 99
Low birth weight and/or prematurity Increased blood pressure 
Salt sensitivity 
Proteinuria 
Reduced GFR 
Reduced renal functional reserve 
Accelerated progression of primary renal 
disease 
Chronic kidney disease 
End-stage kidney disease 
Death 
Low nephron number 
 
Increased blood pressure 
Increased glomerular volume 
Possible predisposition to renal failure in 
neonates 
Reduced renal size Increased blood pressure 
Salt sensitivity 
Reduced GFR 
High birth weight/ maternal diabetes Proteinuria 
Reduced renal functional reserve 
End-stage kidney disease 
Rapid increase in weight/BMI in 
childhood and adolescence, especially 
after low birth weight 
Faster progression of renal   disease 
Larger glomeruli 
Higher blood pressure 
Diabetes, impaired glucose tolerance 
Cardiovascular disease and death 
Obesity 
Metabolic syndrome 
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 Figure 1: Schematic diagram of factors impacting developmental programming of 
hypertension and kidney disease 
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Figure 2: Worldwide percent prevalences of factors impacting programming of 
renal disease, by United Nations region  
 
Error bars represent range of percentage  by  region.  *Vitamin  A  deficiency  numbers  exclude  countries  with  2005  GDP  ≥  USD 15 000, 
where deficiency presumed absent. #Obesity figures for North America and Europe extrapolated from data in “developed  countries”.  
Childhood  obesity  defined  as  ≥  2  SD  from  weight  for  height  median.  Data pooled from references 11, 36, 39, 82, 100 
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